Curve raises €3M seed funding for precision fermentation automation
The company utilizes physical AI to commercialize the process, operating a live pilot with an expanding customer pipeline while seeking backers.
See the latest news and media coverage for Curve. We track all announcements, press releases, and industry mentions in real time, all in one place.
Scalable biomanufacturing systems for proteins
curvebio.techLast updated
In short: Curve raised €3M in seed funding to automate precision fermentation and reached milestones with its BIOBRIC biomanufacturing platform.
The company utilizes physical AI to commercialize the process, operating a live pilot with an expanding customer pipeline while seeking backers.
She brings biotech expertise to scale the companys hardware and software platform for next generation bioprocessing after returning from the US.
The site validates the BIOBRIC bioreactor platform with customers and partners. The team prepares for the next tech and commercial phase. They invite inquiries about biomanufacturing.
Curve thanks Marten Schmidt, Elsa Axby, and Martin Hedström. More details coming soon.
Lloyds Banking Group is set to acquire Curve Europe, following approval from the Bank of Lithuania, in a move that highlights growing interest from traditional...
The plan allows trapped lenders to sell tokenized claims on deposits, offering buyers an option-like bet on CRV's recovery.
Dr. Singal is the Chief of Hepatology at the University of Texas Southwestern Medical Center, and a Professor in the Department of Internal Medicine and...
Southampton, UK-based start-up Curve Therapeutics has completed a £40.5 million ($51 million) in Series A financing for its drug discovery platform that enables drug screening...
Track Curve and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.